Extrapyramidal rating scale G Chouinard, A Ross-Chouinard, L Annable, BD Jones Can. J. Neurol. Sci. 7, 233, 1980 | 882 | 1980 |
Publication bias: what are the challenges and can they be overcome? R Joober, N Schmitz, L Annable, P Boksa Journal of Psychiatry and Neuroscience 37 (3), 149-152, 2012 | 352 | 2012 |
Sexual dysfunction and plasma prolactin levels in neuroleptic-treated schizophrenic outpatients AM Ghadirian, G Chouinard, L Annable The Journal of nervous and mental disease 170 (8), 463-467, 1982 | 341 | 1982 |
Alprazolam in the treatment of generalized anxiety and panic disorders: a double-blind placebo-controlled study G Chouinard, L Annable, R Fontaine, L Solyom Psychopharmacology 77, 229-233, 1982 | 341 | 1982 |
A prospective study of predictors of poststroke depression A Carota, A Berney, S Aybek, G Iaria, F Staub, F Ghika-Schmid, L Annable, ... Neurology 64, 428-433, 2005 | 293 | 2005 |
Neuroleptic-induced supersensitivity psychosis. G Chouinard, BD Jones, L Annable The American journal of psychiatry, 1978 | 276 | 1978 |
Risperidone in the treatment of Tourette syndrome: a double-blind, placebo-controlled trial Y Dion, L Annable, P Sandor, G Chouinard Journal of clinical psychopharmacology 22 (1), 31-39, 2002 | 268 | 2002 |
Antimanic effect of clonazepam. G Chouinard, SN Young, L Annable Biological psychiatry 18 (4), 451-466, 1983 | 258 | 1983 |
Rebound anxiety in anxious patients after abrupt withdrawal of benzodiazepine treatment R Fontaine, G Chouinard, L Annable Am J Psychiatry 141 (7), 848-852, 1984 | 238 | 1984 |
The panicogenic effects of cholecystokinin-tetrapeptide are antagonized by L-365,260, a central cholecystokinin receptor antagonist, in patients with panic disorder J Bradwejn, D Koszycki, AC du Tertre, H van Megen, J Den Boer, ... Archives of general psychiatry 51 (6), 486-493, 1994 | 204 | 1994 |
The effect of tryptophan on social interaction in everyday life: a placebo-controlled study DS Moskowitz, G Pinard, DC Zuroff, L Annable, SN Young Neuropsychopharmacology 25 (2), 277-289, 2001 | 185 | 2001 |
Factors related to tardive dyskinesia G Chouinard, L Annable, A Ross-Chouinard, JN Nestoros Am J Psychiatry 136 (1), 79-82, 1979 | 183 | 1979 |
The second international reference preparation of erythropoietin, human, urinary, for bioassay L Annable, PM Cotes, MV Mussett Bulletin of the World Health Organization 47, 99-112, 1972 | 157 | 1972 |
Tardive dyskinesia in the era of typical and atypical antipsychotics. Part 2: Incidence and management strategies in patients with schizophrenia HC Margolese, G Chouinard, TT Kolivakis, L Beauclair, R Miller, ... The Canadian Journal of Psychiatry 50 (11), 703-714, 2005 | 156 | 2005 |
Lithium, benzodiazepines, and sexual function in bipolar patients. AM Ghadirian, L Annable, MC Bélanger The American journal of psychiatry 149 (6), 801-805, 1992 | 149 | 1992 |
A 5-year prospective longitudinal study of tardive dyskinesia: factors predicting appearance of new cases. G Chouinard, L Annable, A Ross-Chouinard, P Mercier Journal of clinical psychopharmacology 8 (4), 27S, 1988 | 146 | 1988 |
Alexithymia in Substance Abusers: Persistence and Correlates of Variance L Pinard, JC Negrete, L Annable, N Audet American Journal on Addictions 5 (1), 32-39, 1996 | 141 | 1996 |
Vitamin E in the treatment of tardive dyskinesia: a double-blind placebo-controlled study. CL Shriqui, J Bradwejn, L Annable, BD Jones The American journal of psychiatry 149 (3), 391-393, 1992 | 120 | 1992 |
A double-blind randomized clinical trial of rapid tranquilization with IM clonazepam and IM haloperidol in agitated psychotic patients with manic symptoms. G Chouinard, L Annable, L Turnier, N Holobow, N Szkrumelak Canadian Journal of Psychiatry. Revue Canadienne de Psychiatrie 38, S114-21, 1993 | 114 | 1993 |
A placebo-controlled clinical trial of L-tryptophan in premenstrual dysphoria S Steinberg, L Annable, SN Young, N Liyanage Biological psychiatry 45 (3), 313-320, 1999 | 112 | 1999 |